Actavis taps former Ratiopharm chief as new CEO
Generic pharmaceuticals company Actavis Group has appointed former Ratiopharm leader Claudio Albrecht, PhD, as its new CEO.

Albrecht started his career with Sandoz in 1987 where he served as a managing director in the Netherlands, Germany and the U.S., according to Reykjavik, Iceland-based company. In 2000, he joined generics company Ratiopharm as CEO. In 2008, Albrecht established Cometh, a consultancy that advises pharmaceutical companies, including Actavis, on growth strategies.

Sigurdur Oli Olafsson is standing down as Actavis' CEO, following seven years in senior management roles.



Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup